Podium to Practice: EHA 2026 – Leukemia: Triplet Therapy in IDH1-Mutated AML
OR
Studies / Trials Discussed
S127 – A MULTICENTER PHASE 1B/2 TRIAL OF AZACITIDINE, VENETOCLAX, AND IVOSIDENIB IN IDH1-MUTATED ACUTE MYELOID LEUKEMIA (AML)
Chair
Explore more from your favourite experts – click their name to access their entire library of content.
Studies/trials discussed:
S127 – A MULTICENTER PHASE 1B/2 TRIAL OF AZACITIDINE, VENETOCLAX, AND IVOSIDENIB IN IDH1-MUTATED ACUTE MYELOID LEUKEMIA (AML)
Login to view content
PLease Enter Your Email to view Content
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.